Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
D
Dr. Lal PathLabs Ltd
Score 48/100• Decent
Dr. Lal PathLabs Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health94/100
Valuation 20/100 · PB 11.809
Technical Avoid
1M -5.177% 6M 13.426% 1Y -7.93%
Confidence100%
Low leverage (D/E)No promoter pledge
#286
View details ➜
D
Dr Reddy's Laboratories Ltd
Score 48/100• Decent
Dr Reddy's Laboratories shows potential with a solid business model and growth prospects, but faces challenges in profitability and market sentiment.
Company’s Health86/100
Valuation 40/100 · PB 3.0237
Technical Avoid
1M -5.441% 6M 6.711% 1Y -6.801%
Confidence100%
Low leverage (D/E)No promoter pledge
#287
View details ➜
D
Dhanvantri Jeevan Rekha Ltd
Score 48/100• Risky
Dhanvantri Jeevan Rekha Ltd shows potential in a growing sector, but inconsistent financial performance and valuation concerns warrant caution.
Company’s Health48/100
Valuation 80/100 · PB 1.0673
Technical Watch
1M 25.441% 6M 38.842% 1Y 32.696%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#288
View details ➜
D
Deccan Health Care Ltd
Score 48/100• Risky
Deccan Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health54/100
Valuation 100/100 · PB 0.3459
Technical Avoid
1M -22.13% 6M -23.704% 1Y -45.089%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#289
View details ➜
C
Choksi Laboratories Ltd
Score 48/100• Risky
Choksi Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health48/100
Valuation 40/100 · PB 4.909
Technical Avoid
1M -13.854% 6M 60.077% 1Y 137.714%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#290
View details ➜
C
Chemo Pharma Laboratories Ltd
Score 48/100• Risky
Chemo Pharma Laboratories Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
Company’s Health59/100
Valuation 80/100 · PB 1.4326
Technical Avoid
1M 0.441% 6M -0.751% 1Y 71.004%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#291
View details ➜
C
Centenial Surgical Suture Ltd
Score 48/100• Risky
Centenial Surgical Suture Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health39/100
Valuation 80/100 · PB 1.2671
Technical Avoid
1M -2.998% 6M -18.999% 1Y -24.736%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#292
View details ➜
B
Broach Lifecare Hospital Ltd
Score 48/100• Risky
Broach Lifecare Hospital Ltd shows potential in a growing sector but faces significant risks and challenges that warrant caution.
Company’s Health82/100
Valuation 80/100 · PB 1.109
Technical Avoid
1M -18.61% 6M -10% 1Y -38.489%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#293
View details ➜
B
Bandaram Pharma Packtech Ltd
Score 48/100• Risky
The stock presents several risks, particularly in growth consistency and valuation, making it a risky investment at this time.
Company’s Health72/100
Valuation 60/100 · PB 2.2392
Technical Avoid
1M -11.366% 6M -31.349% 1Y -47.798%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#294
View details ➜
B
Bafna Pharmaceuticals Ltd
Score 48/100• Decent
Bafna Pharmaceuticals has a decent outlook with growth potential, but faces challenges in profitability and market sentiment.
Company’s Health78/100
Valuation 40/100 · PB 4.1795
Technical Watch
1M 24.349% 6M 100.134% 1Y 83.853%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#295
View details ➜
A
Anondita Medicare Ltd
Score 48/100• Risky
Anondita Medicare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health91/100
Valuation 20/100 · PB 20.7614
Technical Momentum
1M 22.393% 6M 54.97% 1Y 54.97%
Confidence100%
No promoter pledgeHealthy profit margins
#296
View details ➜
A
Amerise Biosciences Ltd
Score 48/100• Risky
Amerise Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health50/100
Valuation 100/100 · PB 0.7982
Technical Avoid
1M -9.589% 6M -28.571% 1Y -19.753%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#297
View details ➜
A
Alpa Laboratories Ltd
Score 48/100• Risky
Alpa Laboratories Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside valuation concerns.
Company’s Health80/100
Valuation 80/100 · PB 1.0849
Technical Avoid
1M -5.462% 6M -19.242% 1Y -25.897%
Confidence100%
Low leverage (D/E)No promoter pledge
#298
View details ➜
A
Ajooni Biotech Ltd
Score 48/100• Risky
Ajooni Biotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health63/100
Valuation 80/100 · PB 1.0188
Technical Avoid
1M -1.163% 6M -14.45% 1Y -38.489%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#299
View details ➜
A
Aarey Drugs and Pharmaceuticals Ltd
Score 48/100• Risky
Aarey Drugs and Pharmaceuticals Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health58/100
Valuation 80/100 · PB 1.7782
Technical Momentum
1M 15.379% 6M 65.114% 1Y 27.965%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#300
View details ➜
Showing 286 to 300 of 301 (21 Pages)